Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2025 filings

All 27 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2025, sourced directly from the official regulator.

27 Filings
2025 Period
2025 filings (27)
Filing Released Lang
FDA approves extension for ACCRUFeR®
Regulatory Filings
2025-12-22 English
Block Listing Application
Share Issue/Capital Change
2025-12-18 English
Shield Wins Gold at Titan Branding Awards
Regulatory Filings
2025-12-11 English
Amends Senior Secured Debt Financing
Capital/Financing Update
2025-12-03 English
Initiation of a Phase II Clinical Trial in Japan
Regulatory Filings
2025-11-14 English
ACCRUFeR Pediatric PK Results to be Presented
Regulatory Filings
2025-11-11 English
ACCRUFeR receives Authorisation by Korean Ministry
Regulatory Filings
2025-11-07 English
Q3 2025 Trading Update
Earnings Release Q3 2025
2025-10-23 English
Grant of Share Options to Chief Executive Officer
Director's Dealing
2025-10-14 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-10-01 English
Positive efficacy and tolerance in pediatric trial
Regulatory Filings
2025-10-01 English
£1.5 million placing supporting growth of ACCRUFeR
Share Issue/Capital Change
2025-09-15 English
ACCRUFeR® assigned Priority Review in US by FDA
Regulatory Filings
2025-09-04 English
Interim results for the six months ended 30 Jun 25
Interim / Quarterly Report H1 2025
2025-09-03 English
Data published -European Journal of Heart Failure
Regulatory Filings
2025-08-27 English
Interim results for the six months ended 30 Jun 25
Interim / Quarterly Report H1 2025
2025-08-21 English
Q2 2025 Trading Update
Earnings Release Q2 2025
2025-07-23 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2025-05-22 English
Shield Therapeutics plc 2024 Annual Report and Accounts
Annual Report FY 2024
2025-05-22 English
Audited results for the year ended 31 Dec 2024
Earnings Release FY 2024
2025-04-24 English
Licence Agreement in Japan for ACCRUFeR®
Regulatory Filings
2025-04-22 English
Q1 2025 Trading Update
Regulatory Filings
2025-04-17 English
ACCRUFeR® launched in Canada
Regulatory Filings
2025-03-11 English
PDMR Transaction Notification
Director's Dealing
2025-02-13 English
Grant of Share Options
Remuneration Information
2025-02-13 English
Unaudited full year trading update
Earnings Release FY 2024
2025-02-05 English
Anders Lundstrom appointed CEO
Board/Management Information
2025-01-27 English